Recent Quotes

My Watchlist

Indicators

Omega Therapeutics, Inc. - Common Stock (NQ: OMGA )

0.8369 +0.0245 (+3.02%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	180,790
Open	0.8000
Bid (Size)	0.8103 (11)
Ask (Size)	0.8800 (14)
Prev. Close	0.8124
Today's Range	0.7924 - 0.8800
52wk Range	0.7500 - 6.300
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results

November 14, 2024

From Omega Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session

November 01, 2024

Via Benzinga

Performance

YTD	-71.82%	-71.82%
1 Month	+7.85%	+7.85%
3 Month	-37.08%	-37.08%
6 Month	-65.42%	-65.42%
1 Year	-66.12%	-66.12%

More News

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

October 15, 2024

From Omega Therapeutics

Via GlobeNewswire

A Glimpse Into The Expert Outlook On Omega Therapeutics Through 4 Analysts

August 15, 2024

Via Benzinga

Expert Ratings For Omega Therapeutics

June 18, 2024

Via Benzinga

4 Analysts Have This To Say About Omega Therapeutics

May 07, 2024

Via Benzinga

Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications

September 17, 2024

From Omega Therapeutics

Via GlobeNewswire

Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research

August 14, 2024

From Omega Therapeutics

Via GlobeNewswire

Uber To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Wednesday

August 07, 2024

Via Benzinga

How Is The Market Feeling About Omega Therapeutics?

January 26, 2024

Via Benzinga

OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q2 2024

August 06, 2024

Via InvestorPlace

Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

August 06, 2024

From Omega Therapeutics

Via GlobeNewswire

Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors

June 24, 2024

From Omega Therapeutics

Via GlobeNewswire

Omega Therapeutics To Participate In Two Upcoming Investor Conferences

May 30, 2024

From Omega Therapeutics

Via GlobeNewswire

Omega Therapeutics Appoints Kaan Certel, Ph.D., as Chief Business Officer

May 29, 2024

From Omega Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session

May 13, 2024

Via Benzinga

Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers

May 08, 2024

From Omega Therapeutics

Via GlobeNewswire

OMGA Stock Earnings: Omega Therapeutics Misses EPS, Beats Revenue for Q1 2024

May 06, 2024

Via InvestorPlace

Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

May 06, 2024

From Omega Therapeutics

Via GlobeNewswire

Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting

April 23, 2024

From Omega Therapeutics

Via GlobeNewswire

Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control

April 09, 2024

From Omega Therapeutics

Via GlobeNewswire

OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023

March 28, 2024

Via InvestorPlace

Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update

March 28, 2024

From Omega Therapeutics

Via GlobeNewswire

Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024

March 06, 2024

From Omega Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session

January 11, 2024

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.